ACTIVE

APOTHEEK BREENDONKFARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result6,2 k €-91,9 %over 1 year
Gross margin227,4 k €-31,6 %over 1 year
Equity741,3 k €+0,2 %over 1 year
Workforce1,6 ETP+6,7 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK BREENDONKFARMA is a Private limited company incorporated in 2006. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Puurs-Sint-Amands. It employs on average 1,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0885.726.301
Incorporation
14/12/2006
Legal form
Private limited company
Registered office
Beenhouwerstraat 44
2870 Puurs-Sint-Amands · FlandreSee on map
Contributed capital
258 050,00 €
Latest accounts
31/12/2025
Average workforce
1,6 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 17 financial years

20252024202320222021
Income statement
Gross margin227,4 k €332,6 k €275,7 k €279,4 k €269 k €
EBITDA88,4 k €197,9 k €232,2 k €215,5 k €207,2 k €
Operating result9,2 k €119,3 k €160,2 k €136,2 k €122,7 k €
Net result6,2 k €76,9 k €112,4 k €96,5 k €83,9 k €
Balance sheet
Equity741,3 k €740,1 k €663,2 k €712,3 k €647,5 k €
Total assets1,1 M €1,2 M €1,4 M €1,4 M €1,4 M €
Cash97,8 k €283,5 k €451,2 k €395,4 k €335,9 k €
Debts408,3 k €398,2 k €703,8 k €665,7 k €725,7 k €
Other
Workforce1,6 ETP1,5 ETP0,7 ETP1,0 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

Pharma4Future

Director · since 01 janvier 2025 · 0776.403.737

Represented by Lenaerts SVEN

Active

Ended mandates

Dominique Augustynen

Director · since 14 décembre 2006

Ended
Koenraad Vanderbeke

Director · since 14 décembre 2006

Ended
Dominique Augustynen

Director

Ended
Dominique Augustynen

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date02/07/202605/06/202503/07/202406/07/202307/07/202207/07/2021
General meeting30/06/202612/05/202524/06/202426/06/202327/06/202228/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202602/07/2026DutchPDF
Abridged model31/12/202412/05/202505/06/2025DutchPDF
Abridged model31/12/202324/06/202403/07/2024DutchPDF
Abridged model31/12/202226/06/202306/07/2023DutchPDF
Abridged model31/12/202127/06/202207/07/2022DutchPDF
Abridged model31/12/202028/06/202107/07/2021DutchPDF
Abridged model31/12/201930/06/202015/09/2020DutchPDF
Abridged model31/12/201824/06/201915/07/2019DutchPDF
Abridged model31/12/201730/06/201826/09/2018DutchPDF
Abridged model31/12/201626/06/201703/10/2017DutchPDF
Abridged model31/12/201527/06/201628/06/2016DutchPDF
Abridged model31/12/201429/06/201529/07/2015DutchPDF
Abridged model31/12/201330/06/201428/07/2014DutchPDF
Abridged model31/12/201224/06/201326/06/2013DutchPDF
Abridged model31/12/201125/06/201226/06/2012DutchPDF
Abridged model31/12/201027/06/201105/07/2011DutchPDF
Abridged model31/12/200928/06/201005/07/2010DutchPDF
Abridged model31/12/200829/06/200930/06/2009DutchPDF
Abridged model31/12/200730/06/200828/08/2008DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

Pharma4Future

Director · since 01 janvier 2025 · 0776.403.737

Represented by Lenaerts SVEN

Active

Ended mandates

Dominique Augustynen

Director · since 14 décembre 2006

Ended
Koenraad Vanderbeke

Director · since 14 décembre 2006

Ended
Dominique Augustynen

Director

Ended
Dominique Augustynen

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates17/01/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office07/01/2020
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Capital / shares16/11/2007
    KAPITAAL - AANDELEN
    PDF
  • Other28/12/2006
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20256,2 k €↓
  2. 2024
    Annual accounts 202476,9 k €↓
  3. 2023
    Annual accounts 2023112,4 k €↑
  4. 2022
    Annual accounts 202296,5 k €↑
  5. 2021
    Annual accounts 202183,9 k €↑
  6. 2018
    Annual accounts 20184,1 k €↓
  7. 2017
    Annual accounts 201751,5 k €↑
  8. 2016
    Annual accounts 201631,7 k €↓
  9. 2015
    Annual accounts 201544,6 k €↓
  10. 2014
    Annual accounts 201450,2 k €↑
  11. 2013
    Annual accounts 201349,9 k €↑
  12. 2012
    Annual accounts 201232,2 k €↓
  13. 2011
    Annual accounts 201143,5 k €↑
  14. 2010
    Annual accounts 201028,9 k €↓
  15. 2009
    Annual accounts 200935,3 k €↑
  16. 2008
    Annual accounts 200831,1 k €↑
  17. 2007
    Annual accounts 200716,8 k €
  18. 14/12/2006
    IncorporationPrivate limited company